Dermata Therapeutics Inc Stock Ownership - Who owns Dermata Therapeutics?

Insider buying vs selling

Have Dermata Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when DRMA insiders and whales buy or sell their stock.

DRMA Shareholders

What type of owners hold Dermata Therapeutics Inc stock?
Gerald T. Proehl136.02%3,180,465$4.83MInsider
Proehl Investment Ventures LLC124.27%2,905,544$4.42MInsider
David F. Hale39.49%923,383$1.40MInsider
Munera Maria E. Bedoyatoro4.90%114,630$174.24kInsider
Wendell Wierenga2.67%62,398$94.84kInsider
Kathleen D. Scott1.27%29,584$44.97kInsider
Christopher J. Nardo1.18%27,560$41.89kInsider
Renaissance Technologies LLC1.13%26,400$40.13kInstitution
Andrew Seth Sandler1.03%24,184$36.76kInsider
Brittany Bradrick1.00%23,443$35.63kInsider

1 of 2

DRMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FWBI2.07%97.93%Net SellingNet Selling
NAVB2.26%97.74%Net Buying

Dermata Therapeutics Stock Ownership FAQ

Who owns Dermata Therapeutics?

Dermata Therapeutics (NASDAQ: DRMA) is owned by 1.59% institutional shareholders, 313.45% Dermata Therapeutics insiders, and 0.00% retail investors. Gerald T. Proehl is the largest individual Dermata Therapeutics shareholder, owning 3.18M shares representing 136.02% of the company. Gerald T. Proehl's Dermata Therapeutics shares are currently valued at $4.83M.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.